+987.9%
MRNA vs ILMN
+92.1%
+895.8%
-34.2%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 1y.
| Period | Portfolio | ILMN | Excess | Alpha |
|---|---|---|---|---|
| 1D | +13.1% | -4.9% | +18.0% | +18.6% |
| 7D | +20.6% | -21.6% | +42.2% | +51.5% |
| 30D | +27.1% | -22.9% | +50.0% | +64.8% |
| 3M | +353.4% | +11.6% | +341.8% | +224.1% |
| 6M | +446.3% | +62.5% | +383.7% | +209.5% |
| YTD | +776.2% | +72.7% | +703.4% | +378.9% |
| 1Y | +987.9% | +93.9% | +894.1% | +427.6% |
| All | +987.9% | +92.1% | +895.8% | +427.6% |
Cumulative growth
Daily Returns
Daily percentage return beside ILMN.
Daily Out/Under-Performance
Portfolio return minus ILMN return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ILMN return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 1y: compounded portfolio wealth divided by compounded ILMN wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
1y analysis · Full analysis span regression · 6 months rolling